Cardiac, Coronary Artery Diseases and Cardiovascular Diseases
- PRS CORONARY ARTERY DISEASE
- INTEGRATED RISK (PRS + MONOGENIC)
Breast Cancer
- PRS BREAST CANCER
- INTEGRATED RISK (PRS + MONOGENIC)
Prostate Cancer
- PRS PROSTATE CANCER
- INTEGRATED RISK (PRS + MONOGENIC)
Ancestries
- Genetic ancestry
OmniInsight™ Comprehensive Genomic Risk Evaluation (Advanced PRS + Monogenic) for Common Diseases
- Breast cancer
- Atrial Fibrillation
- Ovarian cancer
- Colorectal Cancer
- Melanoma
- Coronary Artery Disease
- Atrial Fibrillation
- Familial Hypercholesterolemia
- Aortopathy
- Cardiomyopathy
- Type 2 Diabetes
- Stroke
- Alzheimer’s
Genetic Counseling Support
-
All test orders include a complimentary virtual genetic counseling session through Avigena Insight, our expert-led genetic counseling program.
Sessions include:
• Interpretation of test results
• Personalized recommendations and prevention strategies
• Evidence-based clinical guidelines and educational materials
Results are also shared with your referring physician, who remains responsible for your ongoing care and medical decision-making.
Avigena Test
FAQ
You can order the test now through your healthcare provider. A system is being developed to have to set up an in-house ordering process.
The average turnaround time is around 4 weeks, but testing might take up to 2 months.
This test is not currently reimbursed by many insurance companies, but some companies do cover the tests.
Avigena has partnered with a CLIA- and CAP-certified laboratory to conduct the test. The lab adheres to stringent regulations designed to protect patient privacy and genetic data. You can trust that all patient data will be securely stored in a HIPAA-compliant manner.
Test and Report
The Test
Avigena’s PRS tests are noninvasive saliva/blood collection tests that are ordered at your healthcare facility or ordered online and shipped to your home. Patient blood/saliva samples are processed at one of Avigena’s CLIA, CAP laboratory partners. Results are delivered by Avigena through a secure portal within 4 weeks.
The Report
The reports include an ancestry-informed prediction for precise scoring based on each patient’s unique genetic ancestry, age-dependent risk modeling to show how risk changes over time, translation of PRS percentile to risk estimate, and recommendations to mitigate risk based on national guidelines.